Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium: Controlled clinical study in menopause;Isoflavoni di soia, lattobacilli, estratto di magnolia, vitamina D 3 e calcio: Studio clinico controllato in menopausa

Minerva Ginecologica

Volumn 58, Issue 4, 2006, Pages 323-334

  Mucci, Manuela ^a,f   Carraro, C ^b   Mancino, P ^b   Monti, M ^b   Papadia, L S ^c   Volpini, G ^d   Benvenuti, C ^e  

^a Civil Hospital   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c Obstetric and Gynaecology Department   (Italy)

^d ASL RMA Woman Health Centre S Anna   (Italy)

^e Rotta Research Laboratorium   (Italy)

^f NONE   (Italy)

Author keywords

Insomnia; Isoflavones; Magnolia extract; Menopause, therapy; Phytoestrogens

Indexed keywords

CALCIUM; COLECALCIFEROL; ISOFLAVONE; MAGNESIUM; MAGNOLIA BARK EXTRACT; PHYTOESTROGEN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANXIETY; ARTICLE; ASTHENIA; BEHAVIOR DISORDER; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSPAREUNIA; ENZYME MECHANISM; FEMALE; FLUSHING; HEART PALPITATION; HUMAN; INSOMNIA; IRRITABILITY; LACTOBACILLUS; LIBIDO DISORDER; MAGNOLIACEAE; MENOPAUSE; MOOD DISORDER; MULTICENTER STUDY; NIGHT SWEAT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEDATION; VAGINAL DRYNESS; VASOMOTOR DISORDER; WELLBEING;

EID: 33749169685     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mauri M, Ramacciotti D. Menopause and personal bodily changes. Minerva Ginecol 2005;57:Suppl 1:1-9.
2. Gambacciani M. New HRT options for the treatment of menopausal symptoms and the maintenance of quality of life in postmenopausal women. Endocrine 2004;24:231-8.
3. Scheiber MD, Liu JH, Subbiah MTR, Rebar RW Setchell KDR. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 2001;8:384-92.
4. Caputi AP, Arcoraci V, Benvenuti C, Estronet Study group. Soy isoflavones, lactobacilli, vitamin D3 and calcium. Observational study in menopause. Gior It Ost Gin 2006;33:1-11.
5. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-63.
6. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake and body composition in postmenopausal women. Menopause 2003;10:427-32.
7. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 1995;208:40-3.
8. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomised controlled trial. JAMA 2002;288:321-33.
9. Adlercreutz H. Phyto-estrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995;103:103-12.
10. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991;54:1093-100.
11. Duncan AM, Underhill KEW, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999;84:4379-84.
12. Pino AM, Valladares LE, Palma MA, Mancilla AM, Yanez M, Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 2000;85:2797-800.
13. Reinli K, Block G. Phytoestrogen content of foods - a compendium of literature values. Nutr Cancer 1996;26:123-48.
14. Brzezinski A, Adlercreutz H and Shaoul R. Short term effects of phytoestrogen rich diet on postmenopausal women. Menopause 1999;4:89-94.
15. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000;7:236-42.
16. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol - A clue to the effectiveness of soy and its isoflavones. J Nutr 2002;132:3577-84.
17. Watanabe K, Watanabe HY, Goto Y, Yamamoto N, Yoshizaki M. Studies on the active principles of magnolia bark. Centrally acting muscle relaxant activity of magnolol and honokiol. Jpn J Pharmacol 1975;25:605-7.
18. Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol 2000;52:1425-9.
19. Ai J, Wang X, Nielsen M. Honokiol and magnolol selectively interact with GABAA receptor subtypes in vitro. Pharmacology 2001;63:34-41.
20. Watanabe H, Watanabe K, Hagino K. Chemostructural requirement for centrally acting muscle relaxant effect of magnolol and honokiol, neolignane derivatives. J Pharmacobiodyn 1983;6:184-90.
21. Altamura BM. Importance of Mg in physiology and medicine and the need for ion selective electrodes. Scand J Clin Lab Invest 1994;217:5-9.
22. Iseri LT, French JH. Magnesium: nature's physiological calcium blocker. Am Heart J 1984;108:188-94.
23. Mc Lean RM. Magnesium's therapeutic uses. Am J Med 1994; 96:63-76.
24. Machin D and Campbell MJ. Statistical Tables for the Design of Clinical Trials. Boston: Blackwell Scientific; 1987.
25. Colacurci N, Chiantera A, de Novellis V, Fornaro F, Manzella D, Arciello A et al. Soy isoflavones and endothelial function in healthy postmenopausal women. Menopause 2005;12:299-307.
26. Ryder KM, Shorr RI, Bush AJ, Kritchevsky SB, Harris T, Stone K et al. Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects. J Am Geriatr Soc 2005;53:1875-80.